Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $18.97, but opened at $18.51. Ascentage Pharma Group International shares last traded at $18.46, with a volume of 680 shares.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. assumed coverage on Ascentage Pharma Group International in a report on Thursday. They set an “overweight” rating on the stock.
Read Our Latest Stock Report on Ascentage Pharma Group International
Ascentage Pharma Group International Stock Performance
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Read More
- Five stocks we like better than Ascentage Pharma Group International
- How to Invest in Blue Chip Stocks
- Ibotta Stock: Why the Buyback Looks Like a Bullish Bet
- How to Use Stock Screeners to Find Stocks
- Joby Aviation Stock: Analyst Confidence and Smart Money Align
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Momentum Stocks Near 52-Week Highs to Watch for More Growth
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
